W Peter Vandertop
Overview
Explore the profile of W Peter Vandertop including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
4535
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serle M, Tjerkstra M, Coert B, Post R, Vandertop W, Verbaan D, et al.
Can J Neurol Sci
. 2025 Feb;
:1-19.
PMID: 39989170
No abstract available.
2.
Klukowska A, Dol M, Vandertop W, Schroder M, Staartjes V
Eur Spine J
. 2024 Dec;
34(3):1107-1114.
PMID: 39680122
Background: The impact of surgical interventions on lumbar disc herniation (LDH) is often assessed using objective functional impairment (OFI) tests like the five-repetition sit-to-stand (5R-STS) test. This study calculates the...
3.
Klukowska A, Ciobanu-Caraus O, Germans M, Vandertop W, Schroder M, Staartjes V
Spine J
. 2024 Dec;
PMID: 39647639
Background Context: There has been no recent updated comprehensive review of measurement properties focused on the 5-repetition sit-to-stand test (5R-STS) in patients with lumbar degenerative disorders (LDD) that could aid...
4.
Dronkers W, van Rees J, Klemann D, Buis D, Amelink Q, Grunhagen D, et al.
Sci Rep
. 2024 Dec;
14(1):30310.
PMID: 39638838
In previous studies, surgical specialties accounted for most malpractice claims. The objective of the present study was to determine the risk for malpractice claims for physicians working in hospitals. A...
5.
Cornelissen F, He Z, Ciputra E, de Haas R, Beumer-Chuwonpad A, Noske D, et al.
Mol Oncol
. 2024 Oct;
19(3):716-740.
PMID: 39417309
Glioblastoma (GB), the most common and aggressive brain tumor, demonstrates intrinsic resistance to current therapies, resulting in poor clinical outcomes. Cancer progression can be partially attributed to the deregulation of...
6.
Dronkers W, Buis D, Amelink Q, Bouma G, Peul W, Vandertop W, et al.
Neurosurgery
. 2024 Jul;
96(3):673-680.
PMID: 39058041
Background And Objectives: Studying malpractice claims is important to improve quality of health care and patient safety and to educate the individual healthcare providers. The objective of this study was...
7.
Klukowska A, Vandertop W, Schroder M, Staartjes V
Eur Spine J
. 2024 Jun;
33(9):3388-3400.
PMID: 38940854
Introduction: Establishing thresholds of change that are actually meaningful for the patient in an outcome measurement instrument is paramount. This concept is called the minimum clinically important difference (MCID). We...
8.
Denneman N, Post R, Coert B, van den Berg R, Verbaan D, Vandertop W
Neurosurgery
. 2024 Jun;
96(1):96-103.
PMID: 38912823
Background And Objectives: Treatment of patients who present with poor clinical condition is often postponed until neurological improvement is observed. Despite previous studies, it is still unclear how survivors perceive...
9.
Tjerkstra M, Post R, Germans M, Vergouwen M, Jellema K, Koot R, et al.
Neurology
. 2024 May;
102(12):e209169.
PMID: 38788175
Background And Objectives: The results of the ULTRA trial showed that ultra-early and short-term treatment with tranexamic acid (TXA) does not improve clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH). Possibly,...
10.
Ter Wengel P, Reith F, Adegeest C, Fehlings M, Kwon B, Vandertop W, et al.
Brain Spine
. 2024 May;
4:102825.
PMID: 38756860
Introduction: It was not even a century ago when a spinal cord injury (SCI) would inevitably result in a fatal outcome, particularly for those with complete SCI. Throughout history, there...